These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 17903325)
1. Obesity and cardiovascular disease. Pérez Pérez A; Ybarra Muñoz J; Blay Cortés V; de Pablos Velasco P Public Health Nutr; 2007 Oct; 10(10A):1156-63. PubMed ID: 17903325 [TBL] [Abstract][Full Text] [Related]
2. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction. Douketis JD; Sharma AM Semin Vasc Med; 2005 Feb; 5(1):25-33. PubMed ID: 15968577 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
4. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. Després JP J Endocrinol Invest; 2006; 29(3 Suppl):77-82. PubMed ID: 16751711 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study. Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689 [TBL] [Abstract][Full Text] [Related]
6. Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial. Seimon RV; Espinoza D; Finer N; James WP; Legler UF; Coutinho W; Sharma AM; Van Gaal L; Maggioni AP; Sweeting A; Torp-Pedersen C; Gebski V; Caterson ID Int J Obes (Lond); 2015 May; 39(5):849-57. PubMed ID: 25520249 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease. Zomer E; Leach R; Trimmer C; Lobstein T; Morris S; James WP; Finer N Diabetes Obes Metab; 2017 Jan; 19(1):118-124. PubMed ID: 27649286 [TBL] [Abstract][Full Text] [Related]
8. Is weight loss beneficial for reduction of morbidity and mortality? What is the controversy about? Nilsson PM Diabetes Care; 2008 Feb; 31 Suppl 2():S278-83. PubMed ID: 18227497 [TBL] [Abstract][Full Text] [Related]
9. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus. Vasudevan AR; Ballantyne CM Clin Cornerstone; 2005; 7(2-3):7-16. PubMed ID: 16473256 [TBL] [Abstract][Full Text] [Related]
10. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. Wannamethee SG; Shaper AG; Walker M J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145 [TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes: fueling the surge of cardiovascular disease in women. Jones EJ; Appel SJ Nurs Womens Health; 2008 Dec; 12(6):500-13; quiz 514. PubMed ID: 19121055 [No Abstract] [Full Text] [Related]
12. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus. Dutton GR; Lewis CE Prog Cardiovasc Dis; 2015; 58(1):69-75. PubMed ID: 25936906 [TBL] [Abstract][Full Text] [Related]
14. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women. Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011 [TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity. Song SH; Hardisty CA QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009. Meigs JB Diabetes Care; 2010 Aug; 33(8):1865-71. PubMed ID: 20668155 [TBL] [Abstract][Full Text] [Related]
17. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease. Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004 [TBL] [Abstract][Full Text] [Related]
18. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. Caterson ID; Hubbard V; Bray GA; Grunstein R; Hansen BC; Hong Y; Labarthe D; Seidell JC; Smith SC; Circulation; 2004 Nov; 110(18):e476-83. PubMed ID: 15520332 [No Abstract] [Full Text] [Related]
19. Beyond glycemic control: treating the entire type 2 diabetes disorder. Brunton S Postgrad Med; 2009 Sep; 121(5):68-81. PubMed ID: 19820276 [TBL] [Abstract][Full Text] [Related]